Given the strong interest in the role of SHIP1 and SHIP2 in many disease states (including such important disease areas as cancer, obesity and Alzheimer’s disease) [159], several studies have described small molecules that can modulate the phosphatase activity of SHIP1 and/or SHIP2. Here, INPP5D is linked to obesity due to melanocortin 4 receptor deficiency.